Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement

• Status: Unknown status
• Trial end date: 2020-03-15
• Target enrollment: 0
• Participant gender: All

Summary

This is a randomized clinical trial, double-blind, placebo-controlled study with the goal to assess the influence of using N-AcetylCysteyn (NAC) for prevention of AKI (Acute Kidney Injury) in post operatory of valve replacement until their discharge or death

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Sao Paulo General Hospital
• Treatments: Acetylcysteine; N-monoacetylcystine

Criteria

Inclusion Criteria:

• Adults

• Both sex

• Elective replacement valve (mitral or aortic) procedure

Exclusion Criteria:

• Chronic dialysis patients

• Emergency procedures

• Percutaneous procedures

• Pregnants

• Oncologic patients